UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 247

Sortiert nach

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (2), p.184-191

2018

Link zum Volltext

Verfügbarkeit prüfen

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

Medical physics (Lancaster), 2016-06, Vol.43 (6), p.2835-2844

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

Journal of clinical oncology, 2012-09, Vol.30 (25), p.3065-3070

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance

Journal of neuropathology and experimental neurology, 2004-07, Vol.63 (7), p.700-707

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2052-2058

2009

Link zum Volltext

Verfügbarkeit prüfen

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Journal of neurosurgery, 2013-04, Vol.118 (4), p.786-798

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

Journal of clinical oncology, 2014-02, Vol.32 (6), p.535-541

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5294-5304

2005

Link zum Volltext

Verfügbarkeit prüfen

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

Journal of neurosurgery, 2008-11, Vol.109 (5), p.835-841

2008

Link zum Volltext

Verfügbarkeit prüfen

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Neuro-oncology (Charlottesville, Va.), 2020-06, Vol.22 (6), p.830-837

2020

Link zum Volltext

Verfügbarkeit prüfen

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Nature communications, 2024-01, Vol.15 (1), p.493-493, Article 493

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

International journal of radiation oncology, biology, physics, 2011-06, Vol.80 (2), p.347-353

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients

Journal of pain and symptom management, 2007-12, Vol.34 (6), p.628-638

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5603-5609

2008

Link zum Volltext

Verfügbarkeit prüfen

A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer

Clinical cancer research, 2006-10, Vol.12 (19), p.5755-5763

2006

Link zum Volltext

Verfügbarkeit prüfen

Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51

International journal of radiation oncology, biology, physics, 2011-09, Vol.81 (1), p.218-224

2011

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2288-2294

2007

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

Seminars in radiation oncology, 2015-07, Vol.25 (3), p.197-202

2015

Link zum Volltext

Verfügbarkeit prüfen

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

International journal of radiation oncology, biology, physics, 2011-10, Vol.81 (2), p.468-475

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (4), p.401

2016

Link zum Volltext

Verfügbarkeit prüfen

Central neurocytoma: Management recommendations based on a 35-year experience

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (4), p.1145-1154

2007

Link zum Volltext

Verfügbarkeit prüfen

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

The New England journal of medicine, 2016-04, Vol.374 (14), p.1344-1355

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing survival in high-grade gliomas

Seminars in oncology, 2003-12, Vol.30 (6), p.10-14

Buckner, Jan C

2003

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (4), p.1175-1183

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2519-2524

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 247

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

Zeitschrift / SerieMayo Clinic Proceedings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(230)

Publikationsform

Sprache

Englisch
(247)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer

Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51

Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

Central neurocytoma: Management recommendations based on a 35-year experience

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Factors influencing survival in high-grade gliomas

Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study

Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination

Aktive Filter

Suchergebnisse filtern